Loading...
NPI 1134195357 · Ewa Beach, HI · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Clinical Laboratories Of Hawaii LLP is a clinical medical laboratory provider located in Ewa Beach, Hawaii. This profile covers 347 Medicare and 293 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Clinical Laboratories Of Hawaii LLP |
| Address | 91-2135 Fort Weaver Rd |
| City | Ewa Beach |
| State | HI |
| ZIP | 96706 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | February 27, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $45.8M |
| Medicare | $5M |
This provider is heavily Medicaid‑focused: lifetime Medicaid revenue is $45.8M versus Medicare revenue of $5M, so Medicaid dominates the payer mix on scale. The magnitude gap suggests primary operational emphasis and contracting in the state Medicaid market rather than Medicare-driven volume.
Medicare revenue is concentrated in a small set of routine lab services: the precomputed top three Medicare codes account for 41.5% of the provider's Medicare revenue, driven by 36415 (16.1%), 80053 (12.9%), and 80061 (12.6%). Those codes are routine phlebotomy and metabolic/lipid panels, indicating Medicare business is concentrated in high-volume specimen collection and core chemistry panels.
Medicaid revenue shows concentration in high-volume infectious disease testing: the precomputed top three Medicaid codes account for 26.9% of Medicaid revenue, led by 87491 (62K claims, $2.7M, 9.1%), 87635 (55.2K claims, $2.6M, 9.1%), and 87591 (60.4K claims, $2.5M, 8.7%). This mix points to a large share of Medicaid dollars tied to NAAT-based STD/sexually transmitted infection testing.
The code mix across both payers demonstrates a full‑service diagnostic laboratory operation: large volumes for screening and monitoring tests (85025, 80053, 80061, 83036, 84443, 82306) plus substantial culture and sensitivity work (87086, 87077, 87186). High counts for routine panels and A1C (for example, Medicaid 80061 183.1K claims and 83036 143.2K claims) imply ongoing chronic disease monitoring and ambulatory specimen processing at scale.
This provider is a competitive leader on several measures: nationally for Medicare it ranks at or near the top for multiple routine codes (e.g., 36415 ranks #54 of 86467, 100th percentile, labeled “extreme outlier”; 80053 and 80061 also sit at the 100th percentile). Statewide for Medicaid it is frequently the top in‑state performer—87491, 87635, 87591, 87389, 87624 and several other codes rank #1 of in‑state peers (100th percentile), indicating dominant in‑state share for infectious disease and STI testing.
Phlebotomy and specimen collection capacity are major operational attributes: 36415 appears as a top Medicare code (73.9K claims, $591K) and as a high Medicaid volume item (405.5K claims, $810.9K, ranked #2 in‑state, 98th percentile, “extreme outlier”). Those volumes are consistent with a large draw‑station footprint or extensive client network sending specimens to this lab.
The provider has a pronounced COVID and infectious testing footprint across payers: Medicaid 87635 (55.2K claims, $2.6M, rank #1 in‑state, “extreme outlier”) and U0003/U0005 together represent multi‑hundred‑thousand‑dollar Medicaid streams (U0003 $1.7M, U0005 $710.2K), and Medicare U0003 also appears ($84.8K). This pattern signals significant high‑throughput molecular testing capability and pandemic‑era volume retention in Medicaid.
Tenure and profile: the NPI was enumerated 2006-02-27 (~20 years ago), indicating long operational history. Combined with the large Medicaid footprint and repeated high percentile rankings, the data point to an established laboratory business whose core revenue now derives primarily from state Medicaid relationships and high‑volume infectious disease and routine panel testing.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
347 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 73,880 | $10 | $591K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 47,190 | $10 | $471.9K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 35,460 | $10 | $460.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 44,150 | $10 | $353.2K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 18,060 | $20 | $288.9K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 25,490 | $10 | $254.9K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 6,730 | $30 | $195.1K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 11,490 | $10 | $91.9K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 5,020 | $20 | $90.4K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 2,180 | $40 | $87.1K |
Showing 1–10 of 347
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 347 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
347 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 82306 | 2 | 10 | 6,730 | $30 | $203.3K |
| 80053 | 2 | 10 | 30 | $10 | $197.6K |
| 80061 | 2 | 10 | 170 | $10 | $142.4K |
| 84443 | 2 | 10 | 100 | $20 | $134.2K |
| 81479 | 2 | 10 | 50 | $2,530 | $119K |
| 83970 | 2 | 10 | 2,180 | $40 | $111.2K |
| 82043 | 2 | 10 | 18,900 | $10 | $106.3K |
| 82607 | 2 | 10 | 6,890 | $10 | $101.5K |
| 84153 | 2 | 10 | 2,630 | $20 | $79.2K |
| U0003 | 1 | 10 | 980 | $70 | $71.6K |
Showing 1–10 of 347
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
293 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 61,960 | $40 | $2.7M |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 55,190 | $50 | $2.6M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 60,360 | $40 | $2.5M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 183,060 | $10 | $2.2M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 256,990 | $10 | $2.1M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 217,180 | $10 | $2M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 113,830 | $20 | $1.9M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 35,440 | $50 | $1.7M |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 8,440 | $190 | $1.6M |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 143,220 | $10 | $1.3M |
Showing 1–10 of 293
How this provider's Medicaid billing volume and revenue compare to other Hawaii providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Hawaii median
293 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 2 | 10 | 20,440 | $30 | $849.8K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 2 | 10 | 4,430 | $160 | $842.9K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 1 | 10 | 2,090 | $60 | $613.6K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 1 | 20 | 1,060 | $60 | $547.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 8 | 30 | 2,500 | $40 | $455.4K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 1 | 20 | 1,070 | $50 | $440.8K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 1 | 10 | 4,400 | $60 | $433K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 1 | 10 | 60 | $310 | $411.1K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 2 | 20 | 660 | $20 | $408.6K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 2 | 20 | 1,050 | $30 | $375.8K |
Showing 1–10 of 293
Other providers in the same ZIP code as Clinical Laboratories Of Hawaii LLP, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.